Research article Special Issues

Entropy evaluation in inverse Weibull unified hybrid censored data with application to mechanical components and head-neck cancer patients

  • Received: 12 September 2024 Revised: 25 December 2024 Accepted: 08 January 2025 Published: 20 January 2025
  • MSC : 62F10, 62F15, 62N01, 62N02, 62N05

  • Entropy is a scientific term that finds applications in various domains, such as the laws of thermodynamics, where it was initially discovered, as well as statistical physics and information theory. We used unified hybrid censored data to investigate some inverse Weibull distribution entropy metrics. Entropy is defined using three measures: Rényi, Shannon, and Tsallis entropy. The classical estimates of the entropy measures were developed using the unified hybrid censored data, which included both point and approximation confidence intervals. The Bayesian method utilized the Markov Chain Monte Carlo sampling technique to develop Bayesian estimations. This was done by employing two loss functions, namely squared error and general entropy loss functions. Additionally, we delved into the investigation of Bayes credible intervals. Monte Carlo simulations were applied to explain how the estimates functioned at different sample sizes and censoring strategies via some accuracy criteria. Several observations were made in light of the simulation results. To provide a clear explanation of the offered methodologies, two applications using mechanical and cancer data sets were investigated.

    Citation: Refah Alotaibi, Mazen Nassar, Zareen A. Khan, Wejdan Ali Alajlan, Ahmed Elshahhat. Entropy evaluation in inverse Weibull unified hybrid censored data with application to mechanical components and head-neck cancer patients[J]. AIMS Mathematics, 2025, 10(1): 1085-1115. doi: 10.3934/math.2025052

    Related Papers:

    [1] Marcus Martin, Reinand Thompson, Nikhil Tirupathi . Does vitamin D level have effect on COVID-19 outcomes?. AIMS Medical Science, 2023, 10(2): 141-150. doi: 10.3934/medsci.2023012
    [2] Gasim Dobie, Sarah Abutalib, Wafa Sadifi, Mada Jahfali, Bayan Alghamdi, Asmaa Khormi, Taibah Alharbi, Munyah Zaqan, Zahra M Baalous, Abdulrahim R Hakami, Mohammed H Nahari, Abdullah A Mobarki, Muhammad Saboor, Mohammad S Akhter, Abdullah Hamadi, Denise E Jackson, Hassan A Hamali . The correlation between severe complications and blood group types in COVID-19 patients; with possible role of T polyagglutination in promoting thrombotic tendencies. AIMS Medical Science, 2023, 10(1): 1-13. doi: 10.3934/medsci.2023001
    [3] Chien Chinh Vien, Tuan Van Le, Van Tuyet Thi Nguyen, Thang Nghia Hoang, Phila Nay . Viral load dynamics of SARS-CoV-2 in the moderately symptomatic COVID-19 patients in Dak Lak, Viet Nam, 2021. AIMS Medical Science, 2025, 12(1): 1-12. doi: 10.3934/medsci.2025001
    [4] Mlyashimbi Helikumi, Paride O. Lolika, Steady Mushayabasa . Analysis of Caputo fractional-order model for COVID-19 with non-pharmaceuticals interventions and vaccine hesitancy. AIMS Medical Science, 2023, 10(3): 196-222. doi: 10.3934/medsci.2023017
    [5] Ayema Haque, Areeba Minhaj, Areeba Ahmed, Owais Khan, Palvisha Qasim, Hasan Fareed, Fatima Nazir, Ayesha Asghar, Kashif Ali, Sobia Mansoor . A meta-analysis to estimate the incidence of thromboembolism in hospitalized COVID-19 patients. AIMS Medical Science, 2020, 7(4): 301-310. doi: 10.3934/medsci.2020020
    [6] Melissa R. Bowman Foster, Ali Atef Hijazi, Raymond C. Sullivan Jr, Rebecca Opoku . Hydroxyurea and pyridostigmine repurposed for treating Covid-19 multi-systems dysfunctions. AIMS Medical Science, 2023, 10(2): 118-129. doi: 10.3934/medsci.2023010
    [7] Jonathan Kissi, Daniel Kwame Kwansah Quansah, Jonathan Aseye Nutakor, Alex Boadi Dankyi, Yvette Adu-Gyamfi . Telehealth during COVID-19 pandemic era: a systematic review. AIMS Medical Science, 2022, 9(1): 81-97. doi: 10.3934/medsci.2022008
    [8] Elizabeth Burner, Lucy Liu, Sophie Terp, Sanjay Arora, Chun Nok Lam, Michael Menchine, Daniel A Dworkis, Sarah Axeen . Increased risk of diabetic ketoacidosis in an Urban, United States, safety-net emergency department in the COVID-19 era. AIMS Medical Science, 2023, 10(1): 37-45. doi: 10.3934/medsci.2023004
    [9] Masoud Nazemiyeh, Mehrzad Hajalilou, Mohsen Rajabnia, Akbar Sharifi, Sabah Hasani . Diagnostic value of Endothelin 1 as a marker for diagnosis of pulmonary parenchyma involvement in patients with systemic sclerosis. AIMS Medical Science, 2020, 7(3): 234-242. doi: 10.3934/medsci.2020014
    [10] Elżbieta Marczak, Maria Szarras-Czapnik, Małgorzata Wójcik, Agata Zygmunt-Górska, Jerzy Starzyk, Karolina Czyżowska, Anna Szymańska, Katarzyna Gołąb-Jenerał, Agnieszka Zachurzok, Elżbieta Moszczyńska . Hypopituitarism—A rare manifestation in Joubert syndrome: about 4 cases. AIMS Medical Science, 2024, 11(3): 318-329. doi: 10.3934/medsci.2024022
  • Entropy is a scientific term that finds applications in various domains, such as the laws of thermodynamics, where it was initially discovered, as well as statistical physics and information theory. We used unified hybrid censored data to investigate some inverse Weibull distribution entropy metrics. Entropy is defined using three measures: Rényi, Shannon, and Tsallis entropy. The classical estimates of the entropy measures were developed using the unified hybrid censored data, which included both point and approximation confidence intervals. The Bayesian method utilized the Markov Chain Monte Carlo sampling technique to develop Bayesian estimations. This was done by employing two loss functions, namely squared error and general entropy loss functions. Additionally, we delved into the investigation of Bayes credible intervals. Monte Carlo simulations were applied to explain how the estimates functioned at different sample sizes and censoring strategies via some accuracy criteria. Several observations were made in light of the simulation results. To provide a clear explanation of the offered methodologies, two applications using mechanical and cancer data sets were investigated.



    In December 2019, a new virus from the coronavirus family, similar to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and Middle East respiratory syndrome–related coronavirus (MERS-CoV), caused new cases of pneumonia in Wuhan, China [1],[2]. According to the World Health Organization (WHO), the disease was named COVID-19 on March 11 and was declared a global emergency. According to the WHO reports, from the beginning of the disease until December 21, 2020, more than 75,700,000 cases have been diagnosed globally, which indicates rapid spread of the disease [3].

    Although COVID-19 affects the respiratory system and main clinical manifestations of the infection present in the upper and lower respiratory system, cutaneous manifestations have been reported in some case series [4],[5]. These manifestations can be in the form of morbilliform or urticarial mimicking viral exanthema, papulovesicular, maculopapular and erythematous lesions, or less commonly varicella-like vesicles [4],[6],[7],[8].

    Here, we present 3 patients with COVID-19 who developed papular cutaneous manifestation which disappeared without specific treatment.

    From May 2020 to October 2020, three patients without previous history of any specific illness or recent drug use leading to drug interactions, were admitted to our hospital with suspected symptoms of COVID-19. Demographic and clinical features of the 3 patients are summarized in Table 1. All of them were men (n = 3) and the median age was 35.3 years (range, 33–39 years). All patients had fever, dry cough and mild to moderate dyspnea. Also 66% (n = 2) had body ache. Considering COVID-19 outbreak in the area, reverse transcription polymerase chain reaction (RT-PCR) test for coronavirus on nasopharyngeal specimen was done which was positive for all three patients. Their chest CT-scan revealed bilateral ground-glass opacity features which compatible with COVID-19.

    For all the patients, Hydroxychloroquine, Azithromycin, Naproxen and Vitamin D were administered. On average after 11 days (range, 3–17 days), diffuse small to moderate-sized cutaneous lesions were developed on trunk (100%, n = 3), back (66%, n = 2) and upper limbs (66%, n = 2) in the form of reddish papular lesions without secretions (Figures 13). No mucosal involvement was found in examination. Moderate itching was reported in 33% of patients (n = 1). As the lesions began to disappear in one anatomic area, they began to appear in another area. On average after 6 days (range 5–8), the lesions started to disappear without any specific treatments. At first the lesions became dark and then disappeared. Lesional biopsy performed on one of the patients (patient's ID:3) and revealed infiltration of PMNs in epidermis, mild hyperkeratosis and acanthosis (Figure 4).

    Table 1.  Demographic and clinical features of the patients.
    ID Sex Age Skin Lesions Skin Symptoms Localization Latency time (days) Duration (days) Systemic Symptoms
    1 M 34 papular Itching No pain Trunk, Back, Upper limbs 3 8 Fever, Cough, Dyspnea, Body ache
    2 M 33 papular No itching No pain Trunk, Back 17 5 Fever, Cough, Dyspnea, Body ache
    3 M 39 papular No itching No pain Trunk, Back, Upper limbs 15 5 Fever, Cough, Dyspnea

     | Show Table
    DownLoad: CSV
    Figure 1.  Patient's ID:1 Cutaneous manifestations on upper limbs and dark lesions remaining after recovery.
    Figure 2.  Patient's ID:2 Cutaneous manifestations on trunk and dark lesion remaining after recovery on his back.
    Figure 3.  Patient's ID:3 Cutaneous manifestations on trunk, upper limps and back. dark lesion remaining after recovery on back.
    Figure 4.  Lesional biopsy performed and histological evaluation revealed infiltration of PMSs in epidermis, mild hyperkeratosis and acanthosis.

    COVID-19 after its widespread outbreak in Wuhan, China, has spread rapidly across Asia and entire the world, becoming a health challenge and concern for the global medical system. Initially, the range of symptoms was limited to a viral respiratory infection such as dry cough, low-grade fever, and headache; But over time, newer symptoms of the disease have been seen and reported in other organs of the body, including loss of smell and taste, diarrhea and body aches, and etc [2],[9]. Also, recent studies which have investigated clinical features of COVID-19 have shown that this infection can be associated with a range of cutaneous manifestations like maculopapular, papulovesicular, pityriasis rosea-like, urticarial, gangrene, pseudoperniosis, livedo reticularis pustular lesions In a Meta-Analysis by Sameni et al. [10] which reviewed 43 studies, the incidence of such cases was 0.2% in Asian studies especially in China and Thailand. Based on their study, the most common types of cutaneous manifestations were erythematous lesions, rash, and urticarial and also, out of 48 patients with skin manifestations, 4 have papular lesions.

    According to studies, the involved region are different in patients and can be the abdomen, limbs and even in a few cases the head and face but in most articles it is stated that the main involved region was the abdomen [4],[5],[6],[7],[8]. As we have claimed, there is no report in existing studies on association of skin manifestations with the prognosis or severity of infection by SARS-COV-2.

    Considering the presented cases and other similar reports in the literature, cutaneous manifestations could be observed in COVID-19 disease, so it is necessary for physicians and healthcare providers to be aware of cutaneous manifestations of COVID-19 disease. Also, special attention should be paid to skin examinations of patients and if they notice skin manifestations, differentiate them from other viral or dermatological disease and drug reactions with symptoms related to COVID-19 disease.

    Our only limitation was missing histopathological biopsy from skin lesions of other patients and unfortunately only one patient agreed to a biopsy of his lesions. Therefore, we recommend that physicians and healthcare providers persuade and reassure patients similar to us to have a biopsy to reveal more details of this manifestation.



    [1] R. Clausius, The mechanical theory of heat, London, UK: McMillan and Co., 1865.
    [2] C. E. Shannon, A mathematical theory of communication, The Bell System Technical Journal, 27 (1948), 379–423. https://doi.org/10.1002/j.1538-7305.1948.tb01338.x doi: 10.1002/j.1538-7305.1948.tb01338.x
    [3] J. M. Amigó, S. G. Balogh, S. Hernández, A brief review of generalized entropies, Entropy, 20 (2018), 813. https://doi.org/10.3390/e20110813 doi: 10.3390/e20110813
    [4] A. Rényi, On measures of entropy and information, In: Proceedings of the fourth Berkeley symposium on mathematical statistics and probability, volume 1: contributions to the theory of statistics, 1961,547–561.
    [5] C. Tsallis, Possible generalization of Boltzmann–Gibbs statistics, J. Stat. Phys., 52 (1988), 479–487. https://doi.org/10.1007/BF01016429 doi: 10.1007/BF01016429
    [6] R. A. Bantan, M. Elgarhy, C. Chesneau, F. Jamal, Estimation of entropy for inverse Lomax distribution under multiple censored data, Entropy, 22 (2020), 601. https://doi.org/10.3390/e22060601 doi: 10.3390/e22060601
    [7] A. A. Al-Babtain, I. Elbatal, C. Chesneau, M. Elgarhy, Estimation of different types of entropies for the Kumaraswamy distribution, PLoS ONE, 16 (2021), e0249027. https://doi.org/10.1371/journal.pone.0249027 doi: 10.1371/journal.pone.0249027
    [8] T. Brochet, J. Lapuyade-Lahorgue, A. Huat, S. Thureau, D. Pasquier, I. Gardin, et al., A quantitative comparison between Shannon and Tsallis–Havrda–Charvat entropies applied to cancer outcome prediction, Entropy, 24 (2022), 436. https://doi.org/10.3390/e24040436 doi: 10.3390/e24040436
    [9] H. Okasha, M. Nassar, Product of spacing estimation of entropy for inverse Weibull distribution under progressive type-Ⅱ censored data with applications, J. Taibah Univ. Sci., 16 (2022), 259–269. https://doi.org/10.1080/16583655.2022.2046945 doi: 10.1080/16583655.2022.2046945
    [10] H. Ren, X. Hu, Bayesian estimations of Shannon entropy and Rényi entropy of inverse Weibull distribution, Mathematics, 11 (2023), 2483. https://doi.org/10.3390/math11112483 doi: 10.3390/math11112483
    [11] F. M. A. Alam, M. Nassar, On entropy estimation of inverse Weibull distribution under improved adaptive progressively Type-Ⅱ censoring with applications, Axioms, 12 (2023), 751. https://doi.org/10.3390/axioms12080751 doi: 10.3390/axioms12080751
    [12] E. A. Ahmed, M. El-Morshedy, L. A. Al-Essa, M. S. Eliwa, Statistical inference on the entropy measures of gamma distribution under progressive censoring: EM and MCMC algorithms, Mathematics, 11 (2023), 2298. https://doi.org/10.3390/math11102298 doi: 10.3390/math11102298
    [13] A. Feutrill, M. Roughan, A review of Shannon and differential entropy rate estimation, Entropy, 23 (2021), 1046. https://doi.org/10.3390/e23081046 doi: 10.3390/e23081046
    [14] A. Z. Keller, M. T. Goblin, N. R. Farnworth, Reliability analysis of commercial vehicle engines, Reliability Engineering, 10 (1985), 15–25. https://doi.org/10.1016/0143-8174(85)90039-3 doi: 10.1016/0143-8174(85)90039-3
    [15] P. Xiuyun, Y. Zaizai, Bayesian estimation and prediction for the inverse Weibull distribution under general progressive censoring, Commun. Stat.-Theor. Meth., 45 (2016), 621–635. https://doi.org/10.1080/03610926.2013.834452 doi: 10.1080/03610926.2013.834452
    [16] K. Lee, Estimation of entropy of the inverse Weibull distribution under generalized progressive hybrid censored data, Journal of the Korean Data and Information Science Society, 28 (2017), 659–668.
    [17] A. S. Hassan, A. N. Zaky, Estimation of entropy for inverse Weibull distribution under multiple censored data, J. Taibah Univ. Sci., 13 (2019), 331–337. https://doi.org/10.1080/16583655.2019.1576493 doi: 10.1080/16583655.2019.1576493
    [18] N. Jana, S. Bera, Interval estimation of multicomponent stress–strength reliability based on inverse Weibull distribution, Math. Comput. Simulat., 191 (2022), 95–119. https://doi.org/10.1016/j.matcom.2021.07.026 doi: 10.1016/j.matcom.2021.07.026
    [19] M. Maswadah, An optimal point estimation method for the inverse Weibull model parameters using the Runge-Kutta method, Aligarh Journal of Statistics, 41 (2021), 1–22.
    [20] M. Kayid, M. A. Alshehri, Modified maximum likelihood estimation of the inverse Weibull model, Axioms, 12 (2023), 961. https://doi.org/10.3390/axioms12100961 doi: 10.3390/axioms12100961
    [21] Z. Mou, G. Liu, J.-Y. Chiang, S. Chen, Inference on the reliability of inverse Weibull with multiply Type-Ⅰ censored data, J. Stat. Comput. Sim., 94 (2024), 2189–2209. https://doi.org/10.1080/00949655.2024.2324366 doi: 10.1080/00949655.2024.2324366
    [22] B. Epstein, Truncated life tests in the exponential case, Ann. Math. Statist., 25 (1954), 555–564. https://doi.org/10.1214/aoms/1177728723 doi: 10.1214/aoms/1177728723
    [23] A. Childs, B. Chandrasekar, N. Balakrishnan, D. Kundu, Exact likelihood inference based on Type-Ⅰ and Type-Ⅱ hybrid censored samples from the exponential distribution, Ann. Inst. Stat. Math., 55 (2003), 319–330. https://doi.org/10.1007/BF02530502 doi: 10.1007/BF02530502
    [24] B. Chandrasekar, A. Childs, N. Balakrishnan, Exact likelihood inference for the exponential distribution under generalized Type-Ⅰ and Type-Ⅱ hybrid censoring, Nav. Res. Log., 51 (2004), 994–1004. https://doi.org/10.1002/nav.20038 doi: 10.1002/nav.20038
    [25] N. Balakrishnan, A. Rasouli, N. Sanjari Farsipour, Exact likelihood inference based on an unified hybrid censored sample from the exponential distribution, J. Stat. Comput. Sim., 78 (2008), 475–488. https://doi.org/10.1080/00949650601158336 doi: 10.1080/00949650601158336
    [26] J. Yu, W. Gui, Y. Shan, Statistical inference on the Shannon entropy of inverse Weibull distribution under the progressive first-failure censoring, Entropy, 21 (2019), 1209. https://doi.org/10.3390/e21121209 doi: 10.3390/e21121209
    [27] R. Xu, W. Gui, Entropy estimation of inverse Weibull distribution under adaptive type-Ⅱ progressive hybrid censoring schemes, Symmetry, 11 (2019), 1463. https://doi.org/10.3390/sym11121463 doi: 10.3390/sym11121463
    [28] K. Lee, Bayesian and maximum likelihood estimation of entropy of the inverse Weibull distribution under generalized type Ⅰ progressive hybrid censoring, Commun. Stat. Appl. Meth., 27 (2020), 469–486. https://doi.org/10.29220/CSAM.2020.27.4.469 doi: 10.29220/CSAM.2020.27.4.469
    [29] S. F. Ateya, Estimation under inverse Weibull distribution based on Balakrishnan's unified hybrid censored scheme, Commun. Stat.-Simul. Comput., 46 (2017), 3645–3666. https://doi.org/10.1080/03610918.2015.1099666 doi: 10.1080/03610918.2015.1099666
    [30] Y. E. Jeon, S. B. Kang, Estimation of the Rayleigh distribution under unified hybrid censoring, Aust. J. Stat., 50 (2021), 59–73. https://doi.org/10.17713/AJS.V50I1.990 doi: 10.17713/AJS.V50I1.990
    [31] A. Alrashidi, A. Rabie, A. A. Mahmoud, S. G. Nasr, M. S. Mustafa, A. Al Mutairi, et al., Exponentiated gamma constant-stress partially accelerated life tests with unified hybrid censored data: statistical inferences, Alex. Eng. J., 88 (2024), 268–275. https://doi.org/10.1016/j.aej.2023.12.066 doi: 10.1016/j.aej.2023.12.066
    [32] W. H. Greene, Econometric analysis, 7 Eds., Upper Saddle River, New Jersey: Pearson Prentice-Hall, 2012.
    [33] A. Elshahhat, W. S. Abu El Azm, Statistical reliability analysis of electronic devices using generalized progressively hybrid censoring plan, Qual. Reliab. Eng. Int., 38 (2022), 1112–1130. https://doi.org/10.1002/qre.3058 doi: 10.1002/qre.3058
    [34] S. Zhou, A. Xu, Y. Tang, L. Shen, Fast Bayesian inference of reparameterized gamma process with random effects, IEEE Trans. Reliab., 73 (2024), 399–412. https://doi.org/10.1109/TR.2023.3263940 doi: 10.1109/TR.2023.3263940
    [35] A. Henningsen, O. Toomet, maxLik: A package for maximum likelihood estimation in R, Comput. Stat., 26 (2011), 443–458. https://doi.org/10.1007/s00180-010-0217-1 doi: 10.1007/s00180-010-0217-1
    [36] M. Plummer, N. Best, K. Cowles, K. Vines, CODA: convergence diagnosis and output analysis for MCMC, R News, 6 (2006), 7–11.
    [37] A. Elshahhat, B. R. Elemary, Analysis for Xgamma parameters of life under Type-Ⅱ adaptive progressively hybrid censoring with applications in engineering and chemistry, Symmetry, 13 (2021), 2112. https://doi.org/10.3390/sym13112112 doi: 10.3390/sym13112112
    [38] R. Alotaibi, M. Nassar, Z. A. Khan, A. Elshahhat, Statistical analysis of stress–strength in a newly inverted Chen model from adaptive progressive Type-Ⅱ censoring and modelling on light-emitting diodes and pump motors, AIMS Math., 9 (2024), 34311–34355. https://doi.org/10.3934/math.20241635 doi: 10.3934/math.20241635
    [39] M. Nassar, R. Alotaibi, A. Elshahhat, E‐Bayesian estimation using spacing function for inverse Lindley adaptive Type‐Ⅰ progressively censored samples: comparative study with applications, Appl. Bionics Biomech., 2024 (2024), 5567457. https://doi.org/10.1155/2024/5567457 doi: 10.1155/2024/5567457
    [40] R. Alotaibi, M. Nassar, Z. A. Khan, A. Elshahhat, Analysis of Weibull progressively first-failure censored data with beta-binomial removals, AIMS Math., 9 (2024), 24109–24142. https://doi.org/10.3934/math.20241172 doi: 10.3934/math.20241172
    [41] I. Elbatal, M. Nassar, A. B. Ghorbal, L. S. G. Diab, A. Elshahhat, Bayesian and E-Bayesian reliability analysis of improved adaptive Type-Ⅱ progressive censored inverted Lindley data, IEEE Access, 12 (2024), 101829–101841. https://doi.org/10.1109/ACCESS.2024.3408042 doi: 10.1109/ACCESS.2024.3408042
    [42] R. Alotaibi, M. Nassar, A. Elshahhat, Analysis of reliability indicators for inverted Lomax model via improved adaptive Type‐Ⅱ progressive censoring plan with applications, Complexity, 2024 (2024), 4848673. https://doi.org/10.1155/2024/4848673 doi: 10.1155/2024/4848673
    [43] M. Nassar, A. Elshahhat, Estimation procedures and optimal censoring schemes for an improved adaptive progressively Type-Ⅱ censored Weibull distribution, J. Appl. Stat., 51 (2024), 1664–1688. https://doi.org/10.1080/02664763.2023.2230536 doi: 10.1080/02664763.2023.2230536
    [44] D. N. P. Murthy, M. Xie, R. Jiang, Weibull models, Hoboken, NJ, USA: Wiley, 2004. https://doi.org/10.1002/047147326X
    [45] H. S. Mohammed, A. Elshahhat, R. Alotaibi, Inferences of inverted gompertz parameters from an adaptive Type-Ⅱ progressive hybrid censoring, Phys. Scr., 98 (2023), 105222. https://doi.org/10.1088/1402-4896/acf5ad doi: 10.1088/1402-4896/acf5ad
    [46] B. Efron, Logistic regression, survival analysis, and the Kaplan-Meier curve, J. Amer. Stat. Assoc., 83 (1988), 414–425. https://doi.org/10.1080/01621459.1988.10478612 doi: 10.1080/01621459.1988.10478612
    [47] A. Elshahhat, M. Nassar, Analysis of adaptive Type-Ⅱ progressively hybrid censoring with binomial removals, J. Stat. Comput. Sim., 93 (2023), 1077–1103. https://doi.org/10.1080/00949655.2022.2127149 doi: 10.1080/00949655.2022.2127149
  • Reader Comments
  • © 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(403) PDF downloads(62) Cited by(0)

Figures and Tables

Figures(7)  /  Tables(15)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog